ZIMHI

Peak

naloxone hydrochloride

NDAINTRAMUSCULAR, SUBCUTANEOUSSOLUTION
Approved
Oct 2021
Lifecycle
Peak
Competitive Pressure
0/100

Loss of Exclusivity

LOE Date
Jun 14, 2041
185 months away
Patent Expiry
Jun 14, 2041

Patent Records (2)

Patent #ExpiryTypeUse Code
11027072
May 24, 2039
Product
—
11571518
Jun 14, 2041
Product
U-3517
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers